BioSpace News Archive

Revecore, through its best-in-class revenue recovery organizations BLS|Revecore and MRA|Revecore, has added seven new health systems with a combined $5 billion in net patient revenue to its client portfolio since executing cross-serving initiatives and launching the Revecore brand in March.

CognitiveRx™ uses machine learning to monitor market demand signals, predict shortage risk and recommend optimal inventory levels

Kleiner Device Labs announced final approval by the Department of Veterans Affairs for making the Kleiner KG®1 lumbar spinal bone graft tool available to VA and military surgeons through Government Marketing and Procurement, a CVE Verified Service Disabled Veteran Owned Small Business, on its VA FSS Schedule 65llA contract, number 36F79719D0049, directly or on GSA Advantage.

The Supreme Cannabis Company, Inc. welcome’s Health Canada’s final regulations for new cannabis products and reiterates its expanded product strategy.

This collaboration marks the first time a tattoo company and a biotechnology & health company have collaborated for the advancement of safety testing and risk assessment of tattoo ink

After an extensive search, Employers Health, a national coalition of employers and other self-funded plan sponsors, has selected EnvisionRx as a preferred pharmacy benefit manager.

The Pittsburgh Life Sciences Greenhouse marks a robust 2019 YTD

National nursing education organization approves accreditation through June 2029

U.S. News & World Report ranks seven specialties among the Top 50 in the nation

Ironshore Pharmaceuticals Inc. (“Ironshore”), a wholly owned subsidiary of Highland Therapeutics Inc. and a leader in the commercialization of novel treatments for Attention Deficit Hyperactivity Disorder (“ADHD”), today announced that JORNAY PM™ (methylphenidate HCl) extended-release capsules CII is now available in the United States.